[ study on association of glioma and cognitive impairments]

ABSTRACT

Given the prevalence of glioma and importance of cognitive impairments of these patients, it is important to evaluate these impairments using the cognitive tests that have previously shown they are capable of these evaluations. Therefore, this study compared cognitive impairment in patients with glioma and controls, in the Shohada Hospital in 2012. Historical cohort study was conducted on patients diagnosed with glioma and control subjects were matched in terms of age, gender and education. Cognitive assessment was done using computerized continuous performance test, Stroop and Tower of London [TOL] tests. Stroop test showed a significant difference between the patient's stroop test variables and the healthy ones [p<0.5], except for the incongruent response time score. In continuous performance test there was a difference between cases and controls [p<0.5]. Variables are assumed to equal for the total error scores of the first 50 stimulants and the total true score of the first 50 stimulants variables. TOL test confirmed the difference between patients and healthy people [p<0.5]. It seems that the tests are capable of assessing cognitive impairments in glioma patients.